Vinge Logotype
SvenskaEnglish 18D7E0DE-2035-40AE-A740-8F45A358A8F4 Login
  1. Home
  2. Mandates
  3. Vinge has advised Apica in connection with funding round
Mandate

Vinge has advised Apica in connection with funding round

September 05, 2017

Vinge has advised Apica in connection with a 12 MUSD funding round, with the goal of helping Apica expand its market presence in the U.S. and Europe outside of the Nordics.

Among others OXX, SEB Venture Capital, KTH Chalmers Capital and Industrifonden have participated in the round. Apica is a Swedish company providing internet based services conducting load testing and performance analysis of business critical web applications.

Vinge´s team consisted of Johan Larsson, Martin Cronsioe and Marith Welin-Berger.

Related

Vinge advised Precise Biometrics

 Vinge has advised Precise Biometrics AB in connection with the merger with Fingerprint Cards.
March 27, 2026

Vinge has advised Xspray Pharma in connection with its rights issue

Vinge has advised Xspray Pharma AB (publ) in connection with a rights issue of approximately SEK 83 million before transaction costs, with an over-allotment issue of approximately SEK 30 million.
March 26, 2026

Vinge advises Diamyd Medical in connection with directed issuances of shares and warrants of up to SEK 1,166 million

 Vinge advises Diamyd Medical Aktiebolag (“Diamyd Medical”), listed on Nasdaq First North Growth Market, in connection with directed issuances of shares and warrants whereby Diamyd Medical receives gross proceeds of approximately SEK 1,166 million, if all warrants are exercised.
March 25, 2026